Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01877083
Title Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Eisai Co., Ltd.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Duarte California United States Details
La Jolla California United States Details
Whittier California United States Details
Jacksonville Florida United States Details
Canton Ohio United States Details
Cleveland Ohio United States Details
Knoxville Tennessee United States Details
Dallas Texas United States Details
Hong Kong Hong Kong Details
Sha Tin Hong Kong Details
Nagoya Aichi Japan Details
Kashiwa Chiba Japan Details
Akashi Hyogo Japan Details
Kobe Hyogo Japan Details
Natori Miyagi Japan Details
Osaka-Sayama Osaka Japan Details
Chuo-ku Tokyo Japan Details
Koto-Ku Tokyo Japan Details
Fukuoka Japan Details
National Cancer Center Hospital Singapore Singapore Details
National University Hospital Singapore Singapore Details
National Taiwan University Hospital Taipei Taiwan Details
Veterans General Hospital Taipei Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field